pre-seed
Stage
1
Investors
About
Calico Biosystems offers a preclinical oncology drug development platform that tests drug efficacy directly on cryopreserved intact patient tumors using New Approach Methodologies (NAM) combined with AI-driven efficacy scoring to provide predictive data for pharma and biotech companies.
Explore Calico Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.